查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2016994

远端保健市场：按组件、存取类型、应用和最终用户划分－2026-2032年全球市场预测

Telehealth Market by Component, Mode of Access, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，远端保健市场价值将达到 624.3 亿美元，到 2026 年将成长至 739.6 亿美元，到 2032 年将达到 2012.8 亿美元，复合年增长率为 18.20%。

主要市场统计数据
基准年 2025 624.3亿美元
预计年份：2026年 739.6亿美元
预测年份 2032 2012.8亿美元
复合年增长率 (%) 18.20%

全面概述患者行为、技术进步和监管变化如何共同重新定义虚拟护理工作流程和交付模式。

在不断变化的患者期​​望、临床技术的进步以及日益完善的法规环境的推动下，远端保健已从辅助管道发展成为医疗服务的核心要素。随着宽频存取的改善、远端监测设备的日益先进以及消费者对数位互动接受度的提高，虚拟医疗的范围正从一次性就诊扩展到持续的慢性病管理和急性分诊。临床医生正在重塑医疗模式，将虚拟就诊点纳入其工作流程，不再将其视为例外，而是作为标准组成部分。

这是一个重要的结构和营运转折点，将孤立的虚拟咨询转变为连续的、全面的、以结果为导向的医疗保健服务体系。

在远端医疗领域，多项变革正在同步发生，重塑着策略重点。首先，医疗服务模式正从以咨询为中心的模式转向以数据驱动的持续性医疗编配，这种模式依赖于远距监测、非同步通讯和整合式诊疗路径来改善治疗效果并减少摩擦。这种转变需要对后端编配层和新的临床协议进行投资，以确保虚拟诊疗和线下诊疗之间安全可靠的升级和交接。

2025 年的利率变化和贸易政策的转变将如何重塑远距医疗筹资策略、医疗设备采购以及整个医疗保健连续体中的区域远端保健伙伴关係？

近期关税调整和2025年推出的贸易政策措施对远端保健系统内的零件采购、医疗设备采购以及国际供应商关係产生了重大影响。依赖全球化供应链的医疗设备製造商面临投入成本上升导致利润空间受挤压，迫使他们重新评估供应商合约。为此，许多机构加快了供应商多元化进程，并增加了库存缓衝，以确保医疗设备的持续供应，并按计划推进远端监测倡议。

透过进行关键的細項分析，揭示不同临床环境和治疗领域的不同实施路径，可以实现有针对性的投资和专案设计。

终端用户的采用模式清晰地表明了远距医疗走向规模化和整合的路径。诊所优先考虑远端保健，以延长咨询时间和进行后续护理管理；诊断中心则整合远距医疗，以加快分诊速度并减少无故缺席。居家照护机构利用远距监测和虚拟咨询来提高转运过程中的安全性并降低再入院风险；医院则将远端保健整合到急诊和专科工作流程中，以拓展专科诊疗范围。患者本身也越来越受益于使用者友善的介面，并开始使用虚拟医疗服务来获得便利、慢性病管理和心理健康服务，这催生了对跨医疗机构无缝衔接的病人历程的需求。

区域比较分析概述了不同的法规环境、支付方结构和基础设施环境如何影响远端保健部署策略。

在美洲，远距医疗的普及主要由支付主导的试点计画、雇主支持的虚拟医疗计画以及医疗服务提供者之间的紧密合作网络所推动。在该市场，报销创新、企业合约和患者体验是扩大规模的关键驱动因素。在欧洲、中东和非洲，管理体制和基础设施成熟度各不相同，有些地区拥有先进的国家级远端保健框架，而有些地区仍然缺乏网路连接和支付管道。与当地卫生部门建立策略伙伴关係以及扩充性的低频宽解决方案可以加速远距医疗的普及。在亚太地区，以行动优先的人口结构和私营部门对数位医疗的大量投资推动了城市地区的快速普及。然而，都市区地区网路连结的差异和监管的碎片化使得需要采用适应性强的服务模式和本地伙伴关係才能实现更广泛的普及。

平台供应商、设备製造商和医疗保健提供者投资于策略行动和能力建设，以在虚拟医疗领域创造永续的竞争优势。

在整个生态系统中，各公司正致力于应对一系列策略挑战，以维持差异化优势。许多平台供应商正在投资更深入的临床整合和模组化API，以实现与电子健康记录和人群健康管理工具的互通性。医疗设备製造商优先考虑安全韧体、标准化资料格式和服务等级保障，以支援临床级遥测技术。医疗服务提供者正与科技公司合作，共同开发诊疗路径，通常专注于慢性病打包诊疗或专科虚拟诊所。此外，一些机构正优先建构证据组合，包括真实世界结果研究和实施科学，以证明临床疗效并支持与保险公司和监管机构的讨论。

经营团队，以扩大远距远端保健的覆盖范围，确保临床安全，并优化营运绩效。

领导者应优先考虑互通性和数据标准化，以确保远端保健互动能够反映在长期照护记录和分析平台中。投资于以临床医生为中心的设计和系统化的变革管理，可以减少摩擦并促进永续使用。筹资策略应强调模组化合同，将硬体、软体和服务分开，以确保定价柔软性并降低供应链风险。各机构还应制定循证计划，量化临床和营运影响，同时积极与保险公司和监管机构合作，就结果指标和报销途径达成协议。

对混合方法研究设计、主要和次要来源以及检验过程进行详细解释，以得出实用见解和建议。

本报告采用混合方法进行分析，结合了对关键相关人员的访谈、与临床专家的咨询以及对政策文件和已发表临床研究的系统性回顾。主要资讯来源是与医疗机构高阶主管、采购经理和技术架构师的结构化对话，这些对话深入了解了实际部署挑战和商业性趋势。辅助研究包括对监管趋势、技术标准和已发表的成果研究的评估，以补充这些发现并确保与最新证据保持一致。

将营运重点、监管合作和证据产生与综合虚拟医疗计画的长期成功连结起来的决定性整合。

远端医疗不再是实验性工具，而是必须融入医疗机构核心营运模式的策略性功能。其成功取决于技术选择与临床工作流程的契合度、采购系统的建立以及供应链风险的管理，并透过结果和体验指标来展现其价值。监管环境和支付方环境将持续演变。积极与相关人员互动并建构适应性强、以实证医学为基础的计画的机构，最能充分利用虚拟医疗带来的临床和营运效益。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：远端保健市场：按组成部分划分

  • 硬体
  • 软体和服务

第九章：远端保健市场进入方法

  • 整合系统
  • 行动应用
  • 仅限电话/语音
  • 网路为基础的平台

第十章：远端保健市场：依应用领域划分

  • 循环系统
  • 神经病学
  • 肿瘤学
  • 精神病学

第十一章远端保健市场：按最终用户划分

  • 诊所
  • 诊断中心
  • 居家照护
  • 医院
  • 病人

第十二章远端保健市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：远端保健市场：依群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章远端保健市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国远端保健市场

第十六章：中国远端保健市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 20now, Inc.
  • 3Derm Systems, Inc.
  • 98point6, Inc.
  • A&D Medical, Inc.
  • Aemtec GmbH
  • Aerotel Medical Systems Ltd.
  • Agnity, Inc.
  • AMC Health, LLC
  • AMD Global Telemedicine, Inc.
  • American Well Corporation
  • Arizona Telemedicine Program
  • Arkansas e-Link
  • Babylon Health Limited
  • Cisco Systems, Inc.
  • DeliverHealth Solutions LLC
  • Doximity, Inc.
  • HealthTap, Inc.
  • Koninklijke Philips NV
  • MDLive, Inc.
  • Medtronic plc
  • MeMD, Inc.
  • PlushCare, Inc.
  • Teladoc Health, Inc.
Product Code: MRR-030298DFF6A2

The Telehealth Market was valued at USD 62.43 billion in 2025 and is projected to grow to USD 73.96 billion in 2026, with a CAGR of 18.20%, reaching USD 201.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 62.43 billion
Estimated Year [2026] USD 73.96 billion
Forecast Year [2032] USD 201.28 billion
CAGR (%) 18.20%

A comprehensive orientation to how patient behavior, technological advances, and regulatory change are collectively redefining virtual care workflows and delivery models

Telehealth has evolved from an auxiliary channel into a core element of care delivery, propelled by sustained shifts in patient expectations, advances in clinical technologies, and an increasingly supportive regulatory environment. The convergence of improved broadband access, more capable remote monitoring devices, and higher consumer comfort with digital interactions has expanded the scope of virtual care beyond episodic visits to ongoing chronic condition management and acute triage pathways. Clinicians are reconfiguring care models to incorporate virtual touchpoints as standard workflow components rather than exceptions.

Against this backdrop, the health workforce is adapting to new modalities of practice with an emphasis on digital literacy, remote diagnostics, and team-based virtual care. Payers and employers are experimenting with novel reimbursement constructs and value-based approaches that reward outcomes delivered through hybrid care models. In parallel, technology vendors are maturing platform capabilities to address interoperability, security, and user experience, which are essential to clinician adoption and patient retention. The result is a more resilient, accessible, and outcome-focused telehealth landscape that demands strategic planning from providers, payers, and vendors alike.

Key structural and operational inflection points that are converting episodic virtual visits into continuous, integrated, outcome-focused care delivery systems

The telehealth landscape is undergoing several concurrent shifts that are reshaping strategic priorities. First, care delivery is moving from visit-centric models toward continuous, data-driven care orchestrations that rely on remote monitoring, asynchronous messaging, and integrated care pathways to improve outcomes and reduce friction. This transition requires investment in backend orchestration layers and new clinical protocols to ensure safe escalation and handoffs between virtual and in-person care.

Second, technology architectures are transitioning from point solutions toward platform approaches that integrate clinical systems, patient engagement tools, and device telemetry. This consolidation increases the premium on interoperability standards, data governance, and user-centered design. Third, regulatory regimes are evolving to balance access with quality, prompting organizations to invest in compliance frameworks and to engage proactively with payers to secure sustainable reimbursement. Finally, workforce models are changing: clinical teams are blending virtual and in-person roles, and organizations that prioritize clinician experience, training, and clear performance metrics are achieving higher utilization and patient satisfaction rates. Together, these shifts require an integrated strategy that aligns technology investment, clinical change management, and stakeholder engagement.

How 2025 tariff adjustments and trade policy shifts are reshaping telehealth procurement strategies, device sourcing, and partnership geographies across the care continuum

Recent tariff adjustments and trade policy measures introduced in 2025 have had a material effect on component sourcing, device procurement, and international vendor relationships within the telehealth ecosystem. Device manufacturers that rely on globalized supply chains experienced increases in input costs that pressured margins and necessitated re-evaluation of vendor contracts. In response, many organizations accelerated diversification of suppliers and increased inventory buffers to maintain continuity of care device availability and to protect deployment timelines for remote monitoring initiatives.

At the same time, software platform vendors that embed specialized hardware into bundled offerings revisited pricing and commercial models, driving procurement teams to negotiate more granular contractual terms that separate hardware from software services. Healthcare providers and health systems also adjusted capital planning assumptions for large-scale device rollouts, prioritizing interoperable solutions that can leverage domestically produced components or that enable phased procurement to mitigate tariff exposure. Lastly, trade policy changes have influenced partnership geography, prompting strategic assessments of nearshoring and regional vendor hubs to reduce exposure to cross-border tariff volatility and to shorten lead times for critical clinical devices.

Critical segmentation intelligence revealing differentiated adoption pathways across clinical settings and therapeutic areas that inform targeted investment and program design

End-user adoption patterns reveal distinct pathways for scale and integration. Clinics are prioritizing telehealth to extend clinic hours and manage follow-up care, whereas diagnostic centers are integrating teleconsultations to speed triage and reduce no-shows. Home care providers are using remote monitoring and virtual visits to enhance safety during transitions and to lower readmission risk, while hospitals are embedding telehealth into emergency and specialty workflows to extend specialist reach. Patients themselves, increasingly empowered by consumer-friendly interfaces, are using virtual care for convenience, chronic care management, and behavioral health access, creating demand for seamless patient journeys that bridge settings.

Application-level dynamics show differential maturity and clinical complexity. Cardiology applications are centered on long-term rhythm monitoring, hypertension management, and post-procedural follow-up supported by high-fidelity telemetry. Neurology virtual care is advancing through remote assessments, seizure monitoring, and rehabilitation support that leverage wearable sensor data and tele-rehabilitation platforms. Oncology telehealth is enhancing patient navigation, symptom management, and multidisciplinary tumor board coordination without replacing the need for in-person infusion and complex procedures. Psychiatry continues to be one of the most widely adopted telehealth applications, driven by comparatively lower diagnostic equipment needs and high patient demand for accessible behavioral health services. These segmentation insights highlight where organizational investments in workflow redesign, clinician training, and platform capabilities will likely yield the greatest clinical and operational returns.

Comparative regional intelligence outlining how distinct regulatory environments, payer structures, and infrastructure profiles shape telehealth deployment strategies

The Americas continue to drive adoption through payer-led pilots, employer-sponsored virtual care programs, and a dense network of provider integrations; the market emphasizes reimbursement innovation, enterprise contracting, and patient experience as primary levers for scale. Europe, Middle East & Africa exhibit heterogeneous regulatory regimes and infrastructure maturity, with pockets of advanced national telehealth frameworks juxtaposed against areas where connectivity and payment pathways remain nascent; strategic partnerships with regional health authorities and scalable, low-bandwidth solutions can accelerate reach. Asia-Pacific demonstrates rapid uptake in urban centers, supported by mobile-first populations and high private-sector investment in digital health, while disparities in rural connectivity and regulatory fragmentation require adaptable delivery models and local partnerships to unlock broad reach.

Understanding these regional differences is essential for tailoring product features, commercial models, and implementation support. Organizations that sequence market entry based on regulatory clarity, reimbursement pathways, and partner ecosystems are better positioned to deploy repeatable programs and to adapt quickly as national policies evolve.

Strategic behaviors and capability investments among platform vendors, device makers, and provider organizations that create sustainable competitive differentiation in virtual care

Across the ecosystem, companies are converging on a set of strategic imperatives to maintain differentiation. Many platform vendors are deepening their clinical integrations and investing in modular APIs to enable interoperability with electronic health records and population health tools. Device manufacturers are emphasizing secure firmware, standardized data formats, and service-level commitments to support clinical-grade telemetry. Providers are forming partnerships with technology firms to co-develop care pathways, often focusing on chronic disease bundles and specialty virtual clinics. In addition, several organizations have prioritized building evidence portfolios-including real-world outcome studies and implementation science-to demonstrate clinical effectiveness and to support discussions with payers and regulators.

Competitive advantage increasingly depends on the ability to operationalize virtual care at scale: seamless clinician workflows, measurable clinical outcomes, and transparent economics. Firms that combine robust clinical workflows, strong security and compliance postures, and flexible commercial models are best positioned to win long-term enterprise relationships and to support population health initiatives across payers and providers.

Practical and prioritized strategic imperatives that executive teams can implement immediately to expand telehealth reach, secure clinical safety, and optimize operational performance

Leaders should prioritize interoperability and data standards to ensure that telehealth interactions feed reliably into longitudinal care records and analytics platforms. Investing in clinician-centered design and structured change management will reduce friction and increase sustained utilization. Procurement strategies should emphasize modular contracting that separates hardware, software, and services to allow pricing flexibility and to mitigate supply chain risk. Organizations must also engage proactively with payers and regulators to align on outcome measures and reimbursement pathways, while developing evidence-generation plans that quantify clinical and operational impacts.

Operationally, scale requires clear escalation protocols, standardized virtual visit documentation, and performance metrics that tie virtual care activity to clinical outcomes. Workforce strategies should include training, workload design, and incentives that reflect blended virtual and in-person responsibilities. Finally, risk management must cover data security, privacy, and vendor resilience planning; scenario-based stress testing of supply chains and continuity plans will protect program uptime and patient safety. Implementing these recommendations will enable organizations to move from pilot success to enduring, value-driven programs.

Detailed explanation of the mixed-methods research design, primary and secondary data sources, and validation processes used to derive actionable insights and recommendations

The analysis underpinning this report was developed through a mixed-methods approach that combined primary stakeholder interviews, expert clinician consultations, and systematic review of policy documents and published clinical studies. Primary inputs included structured conversations with provider executives, procurement leaders, and technology architects to capture real-world implementation challenges and commercial dynamics. Secondary research complemented these insights with an assessment of regulatory developments, technology standards, and published outcome studies to ensure alignment with current evidence.

Findings were triangulated across data sources to enhance robustness, and methodological limitations were acknowledged where evidence was emerging or uneven across regions. The synthesis prioritized themes that demonstrated both practical applicability and empirical support, and recommendations were stress-tested against plausible operational scenarios. This approach ensures that the report's conclusions are grounded in a combination of practitioner experience and documented trends, enabling leaders to make informed strategic choices while recognizing areas that require ongoing evidence generation.

Conclusive synthesis linking operational priorities, regulatory engagement, and evidence generation to the long-term success of integrated virtual care programs

Telehealth is no longer an experimental channel but a strategic capability that must be integrated into the core operating model of healthcare organizations. Success depends on aligning technology choices with clinical workflows, structuring procurement to manage supply chain risks, and demonstrating value through outcomes and experience metrics. Regulatory and payer landscapes will continue to evolve, and organizations that proactively engage stakeholders and build adaptable, evidence-backed programs will be best positioned to capture the clinical and operational benefits of virtual care.

Looking ahead, leaders should balance immediate operational needs-such as clinician training and interoperability-with medium-term investments in platform resilience and outcome measurement. By doing so, organizations can unlock sustained improvements in access, patient experience, and care continuity across clinical settings and therapeutic areas.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Telehealth Market, by Component

  • 8.1. Hardware
  • 8.2. Software & Services

9. Telehealth Market, by Mode of Access

  • 9.1. Integrated Systems
  • 9.2. Mobile Apps
  • 9.3. Telephonic / Voice Only
  • 9.4. Web-Based Platforms

10. Telehealth Market, by Application

  • 10.1. Cardiology
  • 10.2. Neurology
  • 10.3. Oncology
  • 10.4. Psychiatry

11. Telehealth Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Home Care
  • 11.4. Hospitals
  • 11.5. Patients

12. Telehealth Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Telehealth Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Telehealth Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Telehealth Market

16. China Telehealth Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 20now, Inc.
  • 17.6. 3Derm Systems, Inc.
  • 17.7. 98point6, Inc.
  • 17.8. A&D Medical, Inc.
  • 17.9. Aemtec GmbH
  • 17.10. Aerotel Medical Systems Ltd.
  • 17.11. Agnity, Inc.
  • 17.12. AMC Health, LLC
  • 17.13. AMD Global Telemedicine, Inc.
  • 17.14. American Well Corporation
  • 17.15. Arizona Telemedicine Program
  • 17.16. Arkansas e-Link
  • 17.17. Babylon Health Limited
  • 17.18. Cisco Systems, Inc.
  • 17.19. DeliverHealth Solutions LLC
  • 17.20. Doximity, Inc.
  • 17.21. HealthTap, Inc.
  • 17.22. Koninklijke Philips N.V.
  • 17.23. MDLive, Inc.
  • 17.24. Medtronic plc
  • 17.25. MeMD, Inc.
  • 17.26. PlushCare, Inc.
  • 17.27. Teladoc Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TELEHEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TELEHEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TELEHEALTH MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TELEHEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TELEHEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS TELEHEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. GCC TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. GCC TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. G7 TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 115. G7 TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 116. G7 TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NATO TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 120. NATO TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 121. NATO TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)